Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robots and VR join the fight to recover from nerve and muscle diseases

NCT ID NCT06822231

Symptom relief Sponsor: Istituti Clinici Scientifici Maugeri SpA Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares a high-tech rehabilitation program—using robotic systems, virtual reality, and balance platforms—to standard physical therapy for people with acute neuromuscular diseases like Guillain-Barré syndrome. About 124 adults aged 18 to 80 will participate. The goal is to see if the high-tech approach improves balance, daily function, and quality of life more than traditional methods.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
High-tech rehabilitation (robotic verticalization, virtual reality, stabilometric platform, treadmill with gait analysis)
What this could lead to
If successful, this could provide a more effective rehabilitation approach to help patients with acute neuromuscular diseases regain balance and daily function faster.
What could go wrong
This is a relatively small trial (124 participants) and the high-tech equipment may not be widely available. The benefits over traditional rehab are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 124 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2025

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults with ages ranging from 18 to 80 years. * Patients with a confirmed diagnosis of acute/subacute neuromuscular diseases (e.g. GBS, CIM, CIP) * Time of onset ranging from 15 to 30 days * Patients with lower limb strength (Medical Research Council or MRC) \>=2 in at least two of the flexor and extensor muscles of the following joints: hip, knee and ankle * Possibility of obtaining informed consent Exclusion Criteria: * Patients with unstable medical conditions (e.g. severe cardiovascular diseases, such as "New York Heart Association" - NYHA=4, respiratory distress not compensated by ventilation) that could interfere, in the clinician's judgment, with their ability to safely participate in the study or to perform the assessments related to the protocol. * Patients currently participating in other clinical trials that could interfere with this study. * Pregnant or breastfeeding women.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Critical illness myopathy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute quadriplegic myopathy critical illness polyneuropathy Guillain-Barre syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Critical illness myopathy Critical illness polyneuromyopathy (cipnm) Guillain Barré syndrome

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    8 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Azienda Ospedaliero-Universitaria di Modena

    NOT_YET_RECRUITING

    Modena, 41126, Italy

  • Fondazione Don Carlo Gnocchi Onlus

    NOT_YET_RECRUITING

    Roma, 00135, Italy

  • IRCCS Azienda Ospedaliera Universitaria San Martino - Genova

    NOT_YET_RECRUITING

    Genova, 16132, Italy

  • Istituti Clinici Scientifici Maugeri

    NOT_YET_RECRUITING

    Bari, 70124, Italy

  • Istituti Clinici Scientifici Maugeri

    NOT_YET_RECRUITING

    Montescano, 27040, Italy

  • Istituti Clinici Scientifici Maugeri

    NOT_YET_RECRUITING

    Pavia, 27100, Italy

  • Istituti Clinici Scientifici Maugeri

    NOT_YET_RECRUITING

    Telese Terme, 82037, Italy

  • Istituti Clinici Scientifici Maugeri IRCCS, Milan Institute

    RECRUITING

    Milan, 20138, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.